Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6KFY

SufS from Bacillus subtilis in a resting state at 1.96 angstrom resolution

6KFY の概要
エントリーDOI10.2210/pdb6kfy/pdb
関連するPDBエントリー5ZS9
分子名称Cysteine desulfurase SufS, TRIETHYLENE GLYCOL, DI(HYDROXYETHYL)ETHER, ... (5 entities in total)
機能のキーワードiron, sulfur, cysteine desulfurase, resting state, biosynthetic protein
由来する生物種Bacillus subtilis (strain 168)
タンパク質・核酸の鎖数1
化学式量合計47591.54
構造登録者
Nakamura, R.,Takahashi, Y.,Fujishiro, T. (登録日: 2019-07-09, 公開日: 2020-07-15, 最終更新日: 2023-11-22)
主引用文献Nakamura, R.,Ogawa, S.,Takahashi, Y.,Fujishiro, T.
Cycloserine enantiomers inhibit PLP-dependent cysteine desulfurase SufS via distinct mechanisms.
Febs J., 2022
Cited by
PubMed Abstract: The cysteine desulfurase SufS is a pyridoxal-5'-phosphate-dependent enzyme and is essential for the SUF system, which participates in iron-sulfur cluster biosynthesis. Inhibition of SufS in the SUF system by D-cycloserine (DCS) in Plasmodium falciparum apicoplast has recently been reported, indicating that SufS could be a target for malaria therapeutics. However, the mechanistic details underlying the inhibition of SufS by DCS have not yet been clarified. Moreover, inhibition of SufS by the other enantiomer, L-cycloserine (LCS), has not been investigated. Herein, we investigated the structure-based inhibition mechanisms of SufS by DCS and LCS using Bacillus subtilis SufS, whose catalytic mechanism has been well characterized in comparison to that of the P. falciparum SufS. Surprisingly, DCS- and LCS-mediated inhibitions of SufS occur via distinct mechanisms resulting in pyridoxamine-5'-phosphate (PMP) in DCS-mediated inhibition and PMP-3-hydroxyisoxazole adduct (PMP-isoxazole) in LCS-mediated inhibition. Biochemical and structural evaluation of SufS variants identified conserved His and Arg residues at the active site as the key determinants of the distinct inhibition mechanisms. The importance of structural elements involved in DCS and LCS-mediated inhibitions of SufS provides valuable insights for the structure-based design of new drugs targeting SufS. DATABASE: Structural data are available in PDB database under the accession numbers 6KFY, 7CEO, 7CEP, 7CEQ, 7CER, 7CES, 7CET, 7CEU, 7E6A, 7E6B, 7E6C, 7E6D, 7E6E, and 7E6F.
PubMed: 35395703
DOI: 10.1111/febs.16455
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.97 Å)
構造検証レポート
Validation report summary of 6kfy
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon